Trademark: 97043459
Word
ZACLIPTA
Status
Pending
Status Code
732
Status Date
Wednesday, February 28, 2024
Serial Number
97043459
Mark Type
4000
Filing Date
Friday, September 24, 2021
Published for Opposition
Tuesday, July 12, 2022

Trademark Owner History
Johnson & Johnson - Owner At Publication

Classifications
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Events
Mar 1, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2024
Sou Extension 3 Granted
Feb 28, 2024
Sou Extension 3 Filed
Feb 28, 2024
Sou Teas Extension Received
Aug 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2023
Sou Extension 2 Granted
Aug 23, 2023
Sou Extension 2 Filed
Aug 23, 2023
Sou Teas Extension Received
Mar 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2023
Sou Extension 1 Granted
Feb 28, 2023
Sou Extension 1 Filed
Feb 28, 2023
Sou Teas Extension Received
Sep 6, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 12, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 12, 2022
Published For Opposition
Jun 22, 2022
Notification Of Notice Of Publication E-Mailed
Jun 6, 2022
Approved For Pub - Principal Register
Jun 5, 2022
Assigned To Examiner
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 24, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 26, 2021
New Application Office Supplied Data Entered
Sep 28, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24